Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Sep;38(9):2183–2186. doi: 10.1128/aac.38.9.2183

Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

C Betriu 1, M Gomez 1, A Sanchez 1, A Cruceyra 1, J Romero 1, J J Picazo 1
PMCID: PMC284707  PMID: 7811042

Abstract

The aim of this study was to determine the susceptibility patterns of 100 group B streptococcal strains isolated in our hospital and to ascertain tolerance to penicillin by determining quantitative killing curves. We found two strains with intermediate susceptibility to penicillin and eight strains to ampicillin. Seventeen isolates were tolerant to penicillin, with bacterial counts decreasing 2 to 3 log during the first 8 h but still above 10(2) CFU/ml after 24 h. The kinetic study shows that penicillin tolerance is not rare among group B streptococci isolated in our hospital.

Full text

PDF
2183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. L., Sprunt K. Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B beta-hemolytic streptococci. J Pediatr. 1978 Jul;93(1):69–71. doi: 10.1016/s0022-3476(78)80603-9. [DOI] [PubMed] [Google Scholar]
  2. Baker C. J., Barrett F. F., Gordon R. C., Yow M. D. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr. 1973 Apr;82(4):724–729. doi: 10.1016/s0022-3476(73)80606-7. [DOI] [PubMed] [Google Scholar]
  3. Baker C. J., Webb B. J., Barrett F. F. Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob Agents Chemother. 1976 Jul;10(1):128–131. doi: 10.1128/aac.10.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baker C. N., Thornsberry C., Facklam R. R. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother. 1981 May;19(5):716–725. doi: 10.1128/aac.19.5.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bayer A. S., Chow A. W., Anthony B. F., Guze L. B. Serious infections in adults due to group B streptococci. Clinical and serotypic characterization. Am J Med. 1976 Oct;61(4):498–503. doi: 10.1016/0002-9343(76)90329-6. [DOI] [PubMed] [Google Scholar]
  6. Berkowitz K., Regan J. A., Greenberg E. Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol. 1990 Jan;28(1):5–7. doi: 10.1128/jcm.28.1.5-7.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Borderon J. C., Borderon E., Geslin P., Sissia G., Valla M. Sensibilité aux antibiotiques des streptocoques du groupe B. Pathol Biol (Paris) 1984 Jan;32(1):35–39. [PubMed] [Google Scholar]
  8. Broadbent A. Penicillin tolerance in group B streptococci. J Antimicrob Chemother. 1984 Apr;13(4):396–397. doi: 10.1093/jac/13.4.396. [DOI] [PubMed] [Google Scholar]
  9. Broughton D. D., Mitchell W. G., Grossman M., Hadley W. K., Cohen M. S. Recurrence of group B streptococcal infection. J Pediatr. 1976 Aug;89(2):182–185. doi: 10.1016/s0022-3476(76)80441-6. [DOI] [PubMed] [Google Scholar]
  10. Cunningham R., Walker C., Ridgway E. Prosthetic hip-joint infection associated with a penicillin-tolerant group B streptococcus. J Infect. 1992 Jul;25(1):77–81. doi: 10.1016/0163-4453(92)93609-t. [DOI] [PubMed] [Google Scholar]
  11. Dorand R. D., Adams G. Relapse during penicillin treatment of group B streptococcal meningitis. J Pediatr. 1976 Aug;89(2):188–190. doi: 10.1016/s0022-3476(76)80444-1. [DOI] [PubMed] [Google Scholar]
  12. Franciosi R. A., Knostman J. D., Zimmerman R. A. Group B streptococcal neonatal and infant infections. J Pediatr. 1973 Apr;82(4):707–718. doi: 10.1016/s0022-3476(73)80604-3. [DOI] [PubMed] [Google Scholar]
  13. Handwerger S., Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis. 1985 May-Jun;7(3):368–386. doi: 10.1093/clinids/7.3.368. [DOI] [PubMed] [Google Scholar]
  14. Ishida K., Guze P. A., Kalmanson G. M., Albrandt K., Guze L. B. Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob Agents Chemother. 1982 Apr;21(4):688–690. doi: 10.1128/aac.21.4.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jacobs M. R., Kelly F., Speck W. T. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives. Antimicrob Agents Chemother. 1982 Nov;22(5):897–900. doi: 10.1128/aac.22.5.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. James P. A. Comparison of four methods for the determination of MIC and MBC of penicillin for viridans streptococci and the implications for penicillin tolerance. J Antimicrob Chemother. 1990 Feb;25(2):209–216. doi: 10.1093/jac/25.2.209. [DOI] [PubMed] [Google Scholar]
  17. Jokipii A. M., Jokipii L. Presumptive identification and antibiotic susceptibility of group B streptococci. J Clin Pathol. 1976 Aug;29(8):736–739. doi: 10.1136/jcp.29.8.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kim K. S., Anthony B. F. Penicillin tolerance in group B streptococci isolated from infected neonates. J Infect Dis. 1981 Nov;144(5):411–419. doi: 10.1093/infdis/144.5.411. [DOI] [PubMed] [Google Scholar]
  19. Kim K. S., Yoshimori R. N., Imagawa D. T., Anthony B. F. Importance of medium in demonstrating penicillin tolerance by group B streptococci. Antimicrob Agents Chemother. 1979 Aug;16(2):214–216. doi: 10.1128/aac.16.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lerner P. I., Gopalakrishna K. V., Wolinsky E., McHenry M. C., Tan J. S., Rosenthal M. Group B streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature. Medicine (Baltimore) 1977 Nov;56(6):457–473. doi: 10.1097/00005792-197711000-00001. [DOI] [PubMed] [Google Scholar]
  21. Maduri-Traczewski M., Szymczak E. G., Goldmann D. A. In vitro activity of penicillin and rifampin against group B streptococci. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S586–S592. doi: 10.1093/clinids/5.supplement_3.s586. [DOI] [PubMed] [Google Scholar]
  22. Mayhall C. G., Apollo E. Effect of storage and changes in bacterial growth phase and antibiotic concentrations on antimicrobial tolerance in Staphylococcus aureus. Antimicrob Agents Chemother. 1980 Nov;18(5):784–788. doi: 10.1128/aac.18.5.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Michel M. F., van Leeuwen W. B. Degree and stability of tolerance to penicillin in Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis. 1989 Mar;8(3):225–232. doi: 10.1007/BF01965265. [DOI] [PubMed] [Google Scholar]
  24. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ruiz-Gomez D., Tarpay M. M., Riley H. D. Recurrent group B streptococcal infections: Report of three cases. Scand J Infect Dis. 1979;11(1):35–38. doi: 10.3109/inf.1979.11.issue-1.05. [DOI] [PubMed] [Google Scholar]
  26. Sanders C. C. Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzae. Antimicrob Agents Chemother. 1981 Dec;20(6):843–846. doi: 10.1128/aac.20.6.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Severin M. J., Wiley J. L. Change in susceptibility of group B streptococci to penicillin G from 1968 through 1975. Antimicrob Agents Chemother. 1976 Aug;10(2):380–381. doi: 10.1128/aac.10.2.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sherris J. C. Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother. 1986 Nov;30(5):633–637. doi: 10.1128/aac.30.5.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Siegel J. D., Shannon K. M., DePasse B. M. Recurrent infection associated with penicillin-tolerant group B streptococci: a report of two cases. J Pediatr. 1981 Dec;99(6):920–924. doi: 10.1016/s0022-3476(81)80022-4. [DOI] [PubMed] [Google Scholar]
  30. Stampfl D., Verghese A., Parrino T. Group B streptococcal cellulitis in an adult. Postgrad Med. 1985 Apr;77(5):253–254. doi: 10.1080/00325481.1985.11698965. [DOI] [PubMed] [Google Scholar]
  31. Steinbrecher U. P. Serious infection in an adult due to penicillin-tolerant group B streptococcus. Arch Intern Med. 1981 Nov;141(12):1714–1715. [PubMed] [Google Scholar]
  32. Swingle H. M., Bucciarelli R. L., Ayoub E. M. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. J Infect Dis. 1985 Sep;152(3):515–520. doi: 10.1093/infdis/152.3.515. [DOI] [PubMed] [Google Scholar]
  33. Taylor P. C., Schoenknecht F. D., Sherris J. C., Linner E. C. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother. 1983 Jan;23(1):142–150. doi: 10.1128/aac.23.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Truog W. E., Davis R. F., Ray C. G. Recurrence of group B streptococcal infection. J Pediatr. 1976 Aug;89(2):185–186. doi: 10.1016/s0022-3476(76)80442-8. [DOI] [PubMed] [Google Scholar]
  35. Tuomanen E., Durack D. T., Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother. 1986 Oct;30(4):521–527. doi: 10.1128/aac.30.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES